TrialInvestigational new drugs2003

Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks.

Alison J Davis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.